BusinessWorld Online reports that GLP-1 weight loss drugs such as Wegovy may lower the risk of certain cancers. Details on which cancers are in the full story.
Recap by typeshit. Full story at BusinessWorld Online.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
A short Philstar Life item on PIONEER 8, a trial of oral semaglutide. The material gives only the title, so tap through for the details.
Eligible workers get certain Type 2 diabetes GLP-1 drugs free as part of a benefits expansion covering more than 250 prescriptions, even as starter plan premiums rise.
Fast Company looks at GLP-1 drug users changing the hotel business and the new list of requests travelers are bringing with them.
Loading…